Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    22968453 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Autologous Transplant of EFS-ADA Modified Bone Marrow Cells for ADA-Deficient Severe Combined Immunodeficiency (SCID)
Condition: Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency
Intervention: Genetic: EFS-ADA transduced CD34+ cells from the bone marrow
2 Active, not recruiting MND-ADA Transduction of CD34+ Cells From Children With ADA-SCID
Condition: Severe Combined Immunodeficiency
Intervention: Biological: ADA gene transfer

Indicates status has not been verified in more than two years